All Stories

  1. Ustekinumab treatment for moderate-to-severe plaque psoriasis: eight-year real-life experience
  2. The safety of anti-interleukins monoclonal antibodies for the treatment of psoriasis
  3. Skin immunity and its dysregulation in psoriasis
  4. Pharmacotherapeutic management of psoriasis in adolescents and children
  5. Spotlight on brodalumab in the treatment of plaque psoriasis: the evidence to date
  6. A clinical case of severe disease burden: an erythrodermic psoriatic patient treated with secukinumab
  7. Psoriasis Area and Severity Index response in moderate-severe psoriatic patients switched to adalimumab: results from the OPPSA study
  8. New insight into the pathogenesis of nail psoriasis and overview of treatment strategies
  9. Pharmacokinetic drug evaluation of brodalumab for the treatment of psoriasis
  10. Tildrakizumab for treating psoriasis